GSK plc (GSK)
NYSE
Healthcare
Drug Manufacturers - General
$51.17
▼ -0.16%
Market Cap
$102.91B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.29
52-Wk Range
35.45-61.7
CEO
Luke Victor Miels
Country
GB
Currency
USD
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its…
Open full interactive analysis & DCF →